|
A Bristol Skin Cancer Med & Unsustainable Cost
120 days ago
by Ed Silverman
Less than a month after a report determined that the cost of treating cancer is increasingly becoming unaffordable in many developed countries, the UK’s National Institute for Health and Clinical Excellence has decided that a new and well-received skin cancer med from Bristol-Myers Squibb is simply ...
Pharmalot - pharmalot.com · Rank: 2,230 ·  709 references
|
